explore -WSS

explore

author：knowledge 2025-09-06 04:14:25 - browse：363

A psilocybin mushroom lays inside a clear capsule — Adobe

A single dose of psilocybin may have enduring benefits for people with major depressive disorder, according to a randomized clinical trial published Thursday in the Journal of the American Medical Association.

Several prior studies have suggested that psilocybin, the psychedelic compound produced by certain types of mushrooms, could be a promising way to treat major depression in people for whom antidepressants or counseling aren’t effective. But those studies mostly focused on short-term results, while the new JAMA study looked at psilocybin’s efficacy up to six weeks after the administration of a single dose of psilocybin.

“It’s exciting to see another study that’s coming out that is adding to the evidence base suggesting potential efficacy of psilocybin for depression, amongst other conditions,” said Greg Fonzo, an assistant professor and co-director for the Center for Psychedelic Research and Therapy at the University of Texas at Austin’s Dell Medical School, who was not involved in the study.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： 'The View' co

focus

WSS

Former reverend arrested for allegedly killing 8

Dispute over threat of extinction posed by artificial intelligence looms over surging industry

The biotech scorecard for the 2nd quarter: 12 industry events to watch

Dems pitch expanding Medicare power to negotiate drug prices

Democrats decry new health bill for going easy on private equity

In the gardens at Boston Children's Hospital, families find sanctuary

Wikipedia

explore

hotspot

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Why Marc Tessier

Dobbs anniversary: the lost opportunity of abortion as health care

EMA weighs against approval for Mirati's lung cancer drug

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

The battle over 'scope creep' and who gets to be called 'doctor'

After affirmative action ruling, medical educators look to 'holistic review'

The haunting brain science of long Covid

Jerome Adams on the need for new antivirals for Covid

'The View' co

leisure time

Suspects arrested after 3 women attacked on Manhattan's West Side: Police

What causes rare myocarditis in young men after Covid vaccines?

What to watch for from Zogenix and Amicus clinical trials

What is the Turing Test that determines if computers can think?

What is artificial intelligence? Experts weigh in

What causes rare myocarditis in young men after Covid vaccines?

hotspot

entertainment

focus

knowledge